Company Quick10K Filing
Quick10K
Celgene
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$97.11 705 $68,488
10-Q 2019-09-30 Quarter: 2019-09-30
10-Q 2019-06-30 Quarter: 2019-06-30
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-10-31 Earnings, Exhibits
8-K 2019-08-25 Enter Agreement, Exhibits
8-K 2019-07-30 Earnings, Exhibits
8-K 2019-04-25 Earnings, Exhibits
8-K 2019-04-12 Shareholder Vote, Other Events, Exhibits
8-K 2019-04-04 Other Events
8-K 2019-03-29 Other Events, Exhibits
8-K 2019-03-25 Other Events
8-K 2019-03-08 Regulation FD, Exhibits
8-K 2019-01-31 Earnings, Exhibits
8-K 2019-01-07 Earnings, Exhibits
8-K 2019-01-03 Other Events, Exhibits
8-K 2019-01-02 Enter Agreement, Officers, Exhibits
8-K 2018-11-01 Officers, Exhibits
8-K 2018-10-25 Earnings, Exhibits
8-K 2018-07-26 Earnings, Exhibits
8-K 2018-07-09 Other Events, Exhibits
8-K 2018-06-29 Other Events, Exhibits
8-K 2018-06-28 Other Events, Exhibits
8-K 2018-06-19 Other Events, Exhibits
8-K 2018-06-13 Amend Bylaw, Shareholder Vote, Exhibits
8-K 2018-05-31 Officers, Exhibits
8-K 2018-05-30 Regulation FD
8-K 2018-05-24 Other Events, Exhibits
8-K 2018-04-25 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-04-17 Officers, Exhibits
8-K 2018-04-02 Officers, Other Events, Exhibits
8-K 2018-03-06 M&A, Exhibits
8-K 2018-02-26 Other Events, Exhibits
8-K 2018-02-20 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-02-14 Other Events, Exhibits
8-K 2018-02-13 Officers, Exhibits
8-K 2018-02-08 Enter Agreement, Other Events, Exhibits
8-K 2018-02-02 Other Events, Exhibits
8-K 2018-01-26 Other Events, Exhibits
8-K 2018-01-25 Officers, Exhibits
8-K 2018-01-21 Enter Agreement, Exhibits
8-K 2018-01-08 Earnings, Exhibits
ELAN Elanco Animal Healthrporated 9,483
ENTA Enanta Pharmaceuticals 1,392
IMGN Immunogen 377
SNDX Syndax Pharmaceuticals 274
UROV Urovant Sciences 250
ALPN Alpine Immune Sciences 79
VVUS Vivus 44
ALIM Alimera Sciences 31
CTXR Citius Pharmaceuticals 23
AFMD Affimed 0
CELG 2019-09-30
Part I - Financial Information
Item 1. Financial Statements (Unaudited)
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II - Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 6. Exhibits
EX-31.1 ex311certificationofth.htm
EX-31.2 ex312certificationofth.htm
EX-32.1 ex321certificationofth.htm
EX-32.2 ex322certificationofth.htm

Celgene Earnings 2019-09-30

CELG 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

Document
87.00P1Mfalse--12-31Q320190000816284CELGENE CORP /DE/38000000520000000.010.01115000000011500000009815000009926000000.03550.02250.02750.028750.028750.03250.03250.03450.03450.036250.038750.038750.0390.0390.03950.040.04350.04550.046250.050.05250.0570.022500.028750.680.0480.000.0360.050.0430.680.0480.000.0360.040.0430002000000000.0000.010.015000000500000000281300000281200000 0000816284 2019-01-01 2019-09-30 0000816284 2019-10-29 0000816284 us-gaap:CommonStockMember 2019-01-01 2019-09-30 0000816284 celg:ContingentValueRightsMember 2019-01-01 2019-09-30 0000816284 us-gaap:ProductAndServiceOtherMember 2018-01-01 2018-09-30 0000816284 2019-07-01 2019-09-30 0000816284 2018-07-01 2018-09-30 0000816284 2018-01-01 2018-09-30 0000816284 us-gaap:ProductMember 2018-07-01 2018-09-30 0000816284 us-gaap:ProductAndServiceOtherMember 2018-07-01 2018-09-30 0000816284 us-gaap:ProductMember 2018-01-01 2018-09-30 0000816284 us-gaap:ProductMember 2019-07-01 2019-09-30 0000816284 us-gaap:ProductMember 2019-01-01 2019-09-30 0000816284 us-gaap:ProductAndServiceOtherMember 2019-07-01 2019-09-30 0000816284 us-gaap:ProductAndServiceOtherMember 2019-01-01 2019-09-30 0000816284 2019-09-30 0000816284 2018-12-31 0000816284 2018-09-30 0000816284 2017-12-31 0000816284 us-gaap:TreasuryStockMember 2018-01-01 2018-03-31 0000816284 us-gaap:TreasuryStockMember 2019-01-01 2019-03-31 0000816284 2019-03-31 0000816284 2018-01-01 2018-03-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2019-07-01 2019-09-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000816284 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0000816284 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000816284 2018-04-01 2018-06-30 0000816284 us-gaap:TreasuryStockMember 2018-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000816284 us-gaap:RetainedEarningsMember 2018-01-01 2018-03-31 0000816284 2019-01-01 2019-03-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000816284 2018-03-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-03-31 0000816284 us-gaap:TreasuryStockMember 2019-06-30 0000816284 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000816284 us-gaap:TreasuryStockMember 2018-03-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000816284 us-gaap:RetainedEarningsMember 2019-09-30 0000816284 us-gaap:CommonStockMember 2017-12-31 0000816284 us-gaap:TreasuryStockMember 2017-12-31 0000816284 us-gaap:CommonStockMember 2019-03-31 0000816284 us-gaap:RetainedEarningsMember 2019-06-30 0000816284 us-gaap:AdditionalPaidInCapitalMember 2019-09-30 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000816284 2019-04-01 2019-06-30 0000816284 us-gaap:TreasuryStockMember 2019-03-31 0000816284 us-gaap:CommonStockMember 2018-03-31 0000816284 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000816284 us-gaap:RetainedEarningsMember 2019-07-01 2019-09-30 0000816284 us-gaap:RetainedEarningsMember 2017-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000816284 us-gaap:CommonStockMember 2018-09-30 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000816284 us-gaap:RetainedEarningsMember 2018-09-30 0000816284 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-09-30 0000816284 2018-06-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-03-31 0000816284 us-gaap:RetainedEarningsMember 2019-03-31 0000816284 us-gaap:TreasuryStockMember 2018-09-30 0000816284 us-gaap:RetainedEarningsMember 2018-07-01 2018-09-30 0000816284 us-gaap:RetainedEarningsMember 2018-03-31 0000816284 2019-06-30 0000816284 us-gaap:TreasuryStockMember 2018-07-01 2018-09-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000816284 us-gaap:CommonStockMember 2018-12-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-09-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000816284 us-gaap:RetainedEarningsMember 2018-06-30 0000816284 us-gaap:RetainedEarningsMember 2018-12-31 0000816284 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0000816284 us-gaap:TreasuryStockMember 2019-09-30 0000816284 us-gaap:CommonStockMember 2018-06-30 0000816284 us-gaap:CommonStockMember 2019-06-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryStockMember 2019-07-01 2019-09-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000816284 us-gaap:CommonStockMember 2019-09-30 0000816284 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0000816284 us-gaap:TreasuryStockMember 2018-06-30 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000816284 2019-01-02 2019-01-02 0000816284 celg:ProfessionalFeesMember 2019-09-30 0000816284 celg:BristolMyersSquibbCompanyMember 2019-04-17 0000816284 2019-01-02 0000816284 celg:CelgeneMember 2019-01-02 0000816284 2019-08-26 0000816284 2019-01-01 0000816284 srt:MaximumMember celg:ImpactBiomedicinesIncMember 2019-09-30 0000816284 celg:BeigeneMember 2019-07-01 2019-09-30 0000816284 celg:BristolMyersSquibbCompanyMember 2019-01-02 0000816284 srt:MinimumMember celg:ImpactBiomedicinesIncMember 2019-09-30 0000816284 celg:EmployeeRelatedCostsMember 2019-09-30 0000816284 us-gaap:RetainedEarningsMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201409Member us-gaap:RetainedEarningsMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201803Member us-gaap:RetainedEarningsMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201601Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201802Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201803Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201616Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0000816284 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201802Member us-gaap:RetainedEarningsMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201616Member us-gaap:RetainedEarningsMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201601Member us-gaap:RetainedEarningsMember 2018-01-01 0000816284 us-gaap:AccountingStandardsUpdate201409Member us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0000816284 us-gaap:ProductMember country:US 2018-01-01 2018-09-30 0000816284 celg:HematologyandOncologyMember 2018-07-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember 2019-07-01 2019-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember 2018-01-01 2018-09-30 0000816284 celg:HematologyandOncologyMember country:US 2018-01-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember 2018-01-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember country:US 2019-07-01 2019-09-30 0000816284 celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember country:US 2019-07-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember 2019-01-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember 2019-01-01 2019-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 celg:HematologyandOncologyMember country:US 2019-07-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember 2018-01-01 2018-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember 2018-07-01 2018-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember 2019-07-01 2019-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember 2018-01-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember 2019-01-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:HematologyandOncologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember 2018-01-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember country:US 2019-07-01 2019-09-30 0000816284 celg:HematologyandOncologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember country:US 2019-07-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember country:US 2019-07-01 2019-09-30 0000816284 us-gaap:ProductMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember 2018-07-01 2018-09-30 0000816284 celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember country:US 2019-07-01 2019-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember 2019-07-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember country:US 2018-01-01 2018-09-30 0000816284 us-gaap:ProductMember country:US 2019-01-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 us-gaap:ProductMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember 2018-07-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember 2018-07-01 2018-09-30 0000816284 us-gaap:ProductMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember 2019-07-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember 2019-01-01 2019-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember country:US 2019-01-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember 2018-01-01 2018-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 us-gaap:ProductMember country:US 2018-07-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember country:US 2018-01-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember 2019-01-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember 2019-07-01 2019-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember 2018-07-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember country:US 2018-01-01 2018-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember country:US 2018-07-01 2018-09-30 0000816284 celg:AllOtherHematologyandOncologyMember celg:HematologyandOncologyMember country:US 2018-01-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 celg:HematologyandOncologyMember 2018-01-01 2018-09-30 0000816284 us-gaap:ProductMember country:US 2019-07-01 2019-09-30 0000816284 celg:VidazaMember celg:HematologyandOncologyMember 2019-07-01 2019-09-30 0000816284 celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-07-01 2018-09-30 0000816284 celg:HematologyandOncologyMember 2019-07-01 2019-09-30 0000816284 celg:AbraxaneMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-01-01 2019-09-30 0000816284 us-gaap:ProductMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2018-01-01 2018-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember country:US 2018-01-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember country:US 2018-01-01 2018-09-30 0000816284 celg:PomalystImnovidMember celg:HematologyandOncologyMember 2019-01-01 2019-09-30 0000816284 celg:RevlimidMember celg:HematologyandOncologyMember us-gaap:NonUsMember 2019-07-01 2019-09-30 0000816284 celg:OtezlaMember celg:InflammationandImmunologyMember 2018-07-01 2018-09-30 0000816284 celg:HematologyandOncologyMember 2019-01-01 2019-09-30 0000816284 celg:SalesDiscountsMember 2018-01-01 2018-09-30 0000816284 celg:SalesDiscountsMember 2019-07-01 2019-09-30 0000816284 celg:ProductGrossMember 2018-01-01 2018-09-30 0000816284 celg:ProductGrossMember 2019-07-01 2019-09-30 0000816284 celg:ChargebacksandDistributorServicesFeesMember 2019-01-01 2019-09-30 0000816284 celg:GovernmentRebatesMember 2018-07-01 2018-09-30 0000816284 us-gaap:SalesReturnsAndAllowancesMember 2018-01-01 2018-09-30 0000816284 celg:SalesDiscountsMember 2019-01-01 2019-09-30 0000816284 celg:ChargebacksandDistributorServicesFeesMember 2019-07-01 2019-09-30 0000816284 celg:ProductGrossMember 2018-07-01 2018-09-30 0000816284 celg:GovernmentRebatesMember 2019-01-01 2019-09-30 0000816284 celg:ProductGrossMember 2019-01-01 2019-09-30 0000816284 us-gaap:SalesReturnsAndAllowancesMember 2019-07-01 2019-09-30 0000816284 us-gaap:SalesReturnsAndAllowancesMember 2018-07-01 2018-09-30 0000816284 celg:SalesDiscountsMember 2018-07-01 2018-09-30 0000816284 celg:GovernmentRebatesMember 2019-07-01 2019-09-30 0000816284 celg:GovernmentRebatesMember 2018-01-01 2018-09-30 0000816284 celg:ChargebacksandDistributorServicesFeesMember 2018-01-01 2018-09-30 0000816284 celg:ChargebacksandDistributorServicesFeesMember 2018-07-01 2018-09-30 0000816284 us-gaap:SalesReturnsAndAllowancesMember 2019-01-01 2019-09-30 0000816284 srt:MaximumMember 2019-01-01 2019-09-30 0000816284 srt:MinimumMember 2019-01-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember 2018-03-06 2018-03-06 0000816284 celg:JunoTherapeuticsMember 2018-03-06 0000816284 srt:MinimumMember celg:ImpactBiomedicinesIncMember 2018-02-12 2018-02-12 0000816284 celg:JunoTherapeuticsMember 2018-01-01 2018-09-30 0000816284 celg:ImpactBiomedicinesIncMember 2018-02-12 2018-02-12 0000816284 celg:JunoTherapeuticsMember 2019-01-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember 2018-02-28 0000816284 celg:JunoTherapeuticsMember 2018-03-06 2018-03-31 0000816284 celg:JunoTherapeuticsMember 2018-07-01 2018-09-30 0000816284 celg:ImpactBiomedicinesIncMember 2018-02-12 0000816284 celg:INREBICMember 2019-08-31 0000816284 celg:JunoTherapeuticsMember 2019-07-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember 2018-01-01 2018-03-31 0000816284 srt:MaximumMember celg:ImpactBiomedicinesIncMember 2018-02-12 2018-02-12 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember celg:ExcludedComponentRelatedtoCashFlowHedgeMember 2019-01-01 2019-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-07-01 2018-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-01-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember celg:ExcludedComponentRelatedtoCashFlowHedgeMember 2018-07-01 2018-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-07-01 2019-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember celg:ExcludedComponentRelatedtoCashFlowHedgeMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-07-01 2018-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-07-01 2019-09-30 0000816284 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember celg:ExcludedComponentRelatedtoCashFlowHedgeMember 2019-07-01 2019-09-30 0000816284 celg:AccountingStandardsUpdate201601and201802Member 2017-12-31 0000816284 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-09-30 0000816284 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-01-01 2019-09-30 0000816284 celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2017-12-31 0000816284 celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2018-12-31 0000816284 celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2019-09-30 0000816284 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-01-01 2018-09-30 0000816284 celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2018-01-01 2018-09-30 0000816284 celg:AccountingStandardsUpdate201601and201802Member us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-09-30 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-09-30 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-09-30 0000816284 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2019-09-30 0000816284 celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2018-09-30 0000816284 celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2019-09-30 0000816284 celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2018-01-01 2018-09-30 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-09-30 0000816284 celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2019-01-01 2019-09-30 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-09-30 0000816284 celg:AccountingStandardsUpdate201601and201802Member us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-09-30 0000816284 celg:AccountingStandardsUpdate201601and201802Member celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2017-12-31 0000816284 celg:AccountingStandardsUpdate201601and201802Member celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2017-12-31 0000816284 celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2019-01-01 2019-09-30 0000816284 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2018-12-31 0000816284 us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2017-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2018-09-30 0000816284 celg:AccountingStandardsUpdate201601and201802Member us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember 2017-12-31 0000816284 celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2018-09-30 0000816284 celg:AmortizationofExcludedComponentRelatedtoCashFlowHedgesMember 2017-12-31 0000816284 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0000816284 us-gaap:AccumulatedTranslationAdjustmentMember 2019-09-30 0000816284 celg:AccumulatedNetInvestmentGainLossAttributabletoParentAvailableForSaleDebtSecuritiesAndMarketableSecuritiesMember 2018-12-31 0000816284 us-gaap:InvestmentsMember 2019-01-01 2019-09-30 0000816284 us-gaap:InvestmentsMember 2019-09-30 0000816284 us-gaap:InvestmentsMember 2018-12-31 0000816284 us-gaap:InvestmentsMember 2018-01-01 2018-09-30 0000816284 us-gaap:InvestmentsMember 2018-09-30 0000816284 us-gaap:InvestmentsMember 2017-12-31 0000816284 celg:ZeroCostCollarCurrencyContractsMember us-gaap:FairValueInputsLevel1Member 2019-09-30 0000816284 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel1Member 2019-09-30 0000816284 us-gaap:FairValueInputsLevel2Member 2019-09-30 0000816284 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel3Member 2019-09-30 0000816284 celg:ZeroCostCollarCurrencyContractsMember us-gaap:FairValueInputsLevel3Member 2019-09-30 0000816284 us-gaap:FairValueInputsLevel1Member 2019-09-30 0000816284 us-gaap:FairValueInputsLevel3Member 2019-09-30 0000816284 celg:ZeroCostCollarCurrencyContractsMember us-gaap:FairValueInputsLevel2Member 2019-09-30 0000816284 celg:ZeroCostCollarCurrencyContractsMember 2019-09-30 0000816284 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel2Member 2019-09-30 0000816284 us-gaap:ForwardContractsMember 2019-09-30 0000816284 srt:MaximumMember celg:AvilaTherapeuticsIncMember 2019-09-30 0000816284 srt:MaximumMember celg:JunoTherapeuticsMember 2019-09-30 0000816284 srt:MaximumMember celg:NograPharmaLimitedMember 2019-09-30 0000816284 srt:MaximumMember celg:QuanticelMember 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201601Member 2019-01-01 2019-09-30 0000816284 srt:MaximumMember celg:GloucesterPharmaceuticalsIncMember 2019-09-30 0000816284 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000816284 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0000816284 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel2Member 2018-12-31 0000816284 us-gaap:FairValueInputsLevel1Member 2018-12-31 0000816284 us-gaap:FairValueInputsLevel2Member 2018-12-31 0000816284 us-gaap:ForwardContractsMember 2018-12-31 0000816284 us-gaap:ForwardContractsMember us-gaap:FairValueInputsLevel3Member 2018-12-31 0000816284 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDefaultRateMember us-gaap:IncomeApproachValuationTechniqueMember 2019-09-30 0000816284 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDefaultRateMember us-gaap:IncomeApproachValuationTechniqueMember 2019-09-30 0000816284 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDefaultRateMember us-gaap:IncomeApproachValuationTechniqueMember 2018-12-31 0000816284 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember us-gaap:IncomeApproachValuationTechniqueMember 2018-12-31 0000816284 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember us-gaap:IncomeApproachValuationTechniqueMember 2018-12-31 0000816284 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember us-gaap:IncomeApproachValuationTechniqueMember 2019-09-30 0000816284 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDefaultRateMember us-gaap:IncomeApproachValuationTechniqueMember 2018-12-31 0000816284 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember us-gaap:IncomeApproachValuationTechniqueMember 2019-09-30 0000816284 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDefaultRateMember us-gaap:IncomeApproachValuationTechniqueMember 2018-12-31 0000816284 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember us-gaap:IncomeApproachValuationTechniqueMember 2018-12-31 0000816284 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDefaultRateMember us-gaap:IncomeApproachValuationTechniqueMember 2019-09-30 0000816284 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:ObligationsMember us-gaap:MeasurementInputDiscountRateMember us-gaap:IncomeApproachValuationTechniqueMember 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2019-01-01 2019-09-30 0000816284 celg:ForwardStartingInterestRateSwapsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000816284 celg:ForwardStartingInterestRateSwapsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000816284 celg:CarryingAmountofHedgedLiabilityMember 2019-09-30 0000816284 celg:CumulativeamountFairValueHedgingIncludedinCarryingAmountMember 2019-09-30 0000816284 celg:CarryingAmountofHedgedLiabilityMember 2018-12-31 0000816284 celg:CumulativeamountFairValueHedgingIncludedinCarryingAmountMember 2018-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000816284 celg:OtherIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember celg:OtherIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember celg:InterestIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:InterestIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:InterestIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:InterestIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:OtherIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:OtherIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:OtherIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:InterestIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:OtherIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 celg:InterestIncomeExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:ProductMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-09-30 0000816284 celg:SeniorNotes3.875PercentDue2025Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 celg:SeniorNotes3.900Due2028Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2018-12-31 0000816284 celg:SeniorNotes3.450Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2018-12-31 0000816284 celg:SeniorNotes3.900Due2028Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2018-12-31 0000816284 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 celg:SeniorNotes3.450Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 celg:SeniorNotes3.875PercentDue2025Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2018-12-31 0000816284 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PutOptionMember 2018-12-31 0000816284 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CallOptionMember 2018-12-31 0000816284 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CallOptionMember 2019-09-30 0000816284 us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:PutOptionMember 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2018-01-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:OtherIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:OtherIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:InterestIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:ProductMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-09-30 0000816284 celg:InterestIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember celg:OtherIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-09-30 0000816284 celg:OtherIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember celg:InterestIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:OtherIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:InterestIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:InterestIncomeExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-12-31 0000816284 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-31 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-31 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:OtherIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember celg:OtherIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:OtherIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:InterestIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:InterestIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:ProductMember us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0000816284 celg:OtherIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:InterestIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 celg:InterestIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember celg:InterestIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:SalesRevenueNetMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:OtherIncomeExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:InterestRateSwapMember celg:InterestIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:OtherIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember celg:InterestIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:InterestIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000816284 celg:OtherIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember celg:OtherIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:OtherIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember celg:OtherIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:ProductMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember celg:InterestIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 celg:InterestIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:OtherIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember celg:InterestIncomeExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember celg:EffectsofFairValueandCashFlowHedgingMember us-gaap:SalesRevenueNetMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2019-07-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000816284 celg:ForwardStartingInterestRateSwapsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000816284 celg:ForwardStartingInterestRateSwapsMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember 2019-01-01 2019-09-30 0000816284 celg:HedgingAdjustmentDiscontinuedHedgingRelationshipASU201712Member celg:CarryingAmountofHedgedLiabilityMember 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-01 2018-09-30 0000816284 celg:HedgingAdjustmentDiscontinuedHedgingRelationshipASU201712Member celg:CarryingAmountofHedgedLiabilityMember 2018-12-31 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-01 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000816284 us-gaap:InterestRateSwapMember 2018-01-01 2018-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember 2018-12-31 0000816284 srt:MinimumMember us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000816284 srt:MaximumMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0000816284 celg:HedgingAdjustmentDiscontinuedHedgingRelationshipASU201712Member celg:CumulativeamountFairValueHedgingIncludedinCarryingAmountMember 2019-09-30 0000816284 celg:HedgingAdjustmentDiscontinuedHedgingRelationshipASU201712Member celg:CumulativeamountFairValueHedgingIncludedinCarryingAmountMember 2018-12-31 0000816284 srt:MinimumMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SeniorNotesMember 2019-01-01 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-09-30 0000816284 us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 us-gaap:AccountingStandardsUpdate201712Member us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0000816284 srt:MinimumMember us-gaap:ForeignExchangeForwardMember 2019-01-01 2019-09-30 0000816284 srt:MaximumMember us-gaap:ForeignExchangeOptionMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0000816284 srt:MaximumMember us-gaap:ForeignExchangeForwardMember 2019-01-01 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:SalesMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:InterestExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:TreasuryLockMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2018-07-01 2018-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2018-01-01 2018-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2019-07-01 2019-09-30 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherIncomeMember 2019-01-01 2019-09-30 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-09-30 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2019-09-30 0000816284 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-09-30 0000816284 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 currency:AUD us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 currency:AUD us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:CAD us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:EUR us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:GBP us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:JPY us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 currency:GBP us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 currency:CAD us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 celg:SeniorNotes3.875PercentDue2025Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 celg:SeniorNotes3.900Due2028Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 celg:SeniorNotes3.450Member us-gaap:InterestRateSwapMember us-gaap:SeniorNotesMember 2019-09-30 0000816284 us-gaap:ForeignExchangeOptionMember us-gaap:PutOptionMember 2018-12-31 0000816284 celg:TimeDepositsandRepurchaseAgreementsMember 2018-12-31 0000816284 celg:UltraShortIncomeFundMember 2018-12-31 0000816284 celg:TimeDepositsandRepurchaseAgreementsMember 2019-09-30 0000816284 celg:TechnologyMember 2018-12-31 0000816284 celg:AcquiredInProcessResearchAndDevelopmentProductRightsMember 2019-09-30 0000816284 celg:TechnologyMember 2019-09-30 0000816284 us-gaap:LicensingAgreementsMember 2019-09-30 0000816284 us-gaap:LicensingAgreementsMember 2018-12-31 0000816284 celg:AcquiredInProcessResearchAndDevelopmentProductRightsMember 2018-12-31 0000816284 us-gaap:OtherIntangibleAssetsMember 2018-12-31 0000816284 us-gaap:OtherIntangibleAssetsMember 2019-09-30 0000816284 celg:AcquiredDevelopedProductRightsMember 2019-09-30 0000816284 celg:AcquiredDevelopedProductRightsMember 2018-12-31 0000816284 celg:INREBICMember 2019-01-01 2019-09-30 0000816284 celg:SeniorNotes3.250Due2023Member 2018-02-28 0000816284 celg:SeniorNotes3.900Due2028Member 2018-02-28 0000816284 us-gaap:RevolvingCreditFacilityMember 2019-09-30 0000816284 us-gaap:TreasuryLockMember 2019-09-30 0000816284 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-09-30 0000816284 us-gaap:CommercialPaperMember 2019-09-30 0000816284 celg:A2021202320282048NotesMember 2018-02-28 0000816284 celg:SeniorNotes3.250Due2023Member 2018-02-01 2018-02-28 0000816284 celg:SeniorNotes2.875Due2021Member 2018-02-28 0000816284 celg:SeniorNotes2.250Due2021Member 2019-05-31 0000816284 celg:SeniorNotes4.550Due2048Member 2018-02-28 0000816284 celg:A2021202320282048NotesMember 2018-02-01 2018-02-28 0000816284 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000816284 us-gaap:CommercialPaperMember 2016-04-30 0000816284 celg:SeniorNotes4.550Due2048Member 2018-02-01 2018-02-28 0000816284 celg:SeniorNotes2.250Due2021Member 2019-05-01 2019-05-31 0000816284 celg:SeniorNotes3.900Due2028Member 2018-02-01 2018-02-28 0000816284 celg:SeniorNotes2.875Due2021Member 2018-02-01 2018-02-28 0000816284 us-gaap:SeniorNotesMember 2019-09-30 0000816284 us-gaap:TreasuryLockMember 2018-12-31 0000816284 celg:SeniorNotes3.25PercentDue2022Member 2018-12-31 0000816284 celg:SeniorNotes4.625PercentDue2044Member 2019-09-30 0000816284 celg:SeniorNotes2.250Due2021Member 2019-09-30 0000816284 celg:SeniorNotes5.70PercentDue2040Member 2019-09-30 0000816284 celg:SeniorNotes5.250Due2043Member 2019-09-30 0000816284 celg:SeniorNotes3.950PercentDue2020Member 2019-09-30 0000816284 celg:SeniorNotes3.900Due2028Member 2019-09-30 0000816284 celg:SeniorNotes3.875PercentDue2025Member 2018-12-31 0000816284 celg:SeniorNotes3.950PercentDue2020Member 2018-12-31 0000816284 celg:SeniorNotes2.875Due2020Member 2019-09-30 0000816284 celg:SeniorNotes3.250Due2023Member 2018-12-31 0000816284 celg:SeniorNotes2.750Member 2018-12-31 0000816284 celg:SeniorNotes4.550Due2048Member 2019-09-30 0000816284 celg:SeniorNotes4.625PercentDue2044Member 2018-12-31 0000816284 celg:SeniorNotes3.625PercentDue2024Member 2019-09-30 0000816284 celg:SeniorNotes4.000Due2023Member 2018-12-31 0000816284 celg:SeniorNotes2.750Member 2019-09-30 0000816284 celg:SeniorNoes3.550PercentDue2022Member 2019-09-30 0000816284 celg:SeniorNotes5.250Due2043Member 2018-12-31 0000816284 celg:SeniorNotes3.250Due2023Member 2019-09-30 0000816284 celg:SeniorNotes3.900Due2028Member 2018-12-31 0000816284 celg:SeniorNotes5.000PercentDue2045Member 2019-09-30 0000816284 celg:SeniorNotes3.875PercentDue2025Member 2019-09-30 0000816284 celg:SeniorNotes4.000Due2023Member 2019-09-30 0000816284 celg:SeniorNotes3.450Due2027Member 2019-09-30 0000816284 celg:SeniorNotes2.250Due2021Member 2018-12-31 0000816284 celg:SeniorNotes4.350Due2047Member 2018-12-31 0000816284 celg:SeniorNotes2.875Due2021Member 2019-09-30 0000816284 celg:SeniorNotes3.625PercentDue2024Member 2018-12-31 0000816284 celg:SeniorNotes3.450Due2027Member 2018-12-31 0000816284 celg:SeniorNotes2.875Due2021Member 2018-12-31 0000816284 celg:SeniorNotes3.25PercentDue2022Member 2019-09-30 0000816284 celg:SeniorNotes2.875Due2020Member 2018-12-31 0000816284 celg:SeniorNotes5.000PercentDue2045Member 2018-12-31 0000816284 celg:SeniorNoes3.550PercentDue2022Member 2018-12-31 0000816284 celg:SeniorNotes5.70PercentDue2040Member 2018-12-31 0000816284 celg:SeniorNotes4.350Due2047Member 2019-09-30 0000816284 celg:SeniorNotes4.550Due2048Member 2018-12-31 0000816284 celg:SeniorNotes2.250PercentDue2019Member 2019-09-30 0000816284 celg:SeniorNotes2.875Due2020Member 2019-09-30 0000816284 celg:SeniorNotes2.875Due2020Member 2018-12-31 0000816284 celg:SeniorNotes2.250PercentDue2019Member 2018-12-31 0000816284 us-gaap:CommercialPaperMember 2018-12-31 0000816284 us-gaap:RevolvingCreditFacilityMember 2018-12-31 0000816284 celg:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-09-30 0000816284 celg:PerformanceBasedRestrictedStockUnitsMember 2019-09-30 0000816284 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-09-30 0000816284 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-09-30 0000816284 us-gaap:RestrictedStockUnitsRSUMember 2019-09-30 0000816284 us-gaap:EmployeeStockOptionMember 2019-09-30 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0000816284 us-gaap:CostOfSalesMember 2018-07-01 2018-09-30 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000816284 us-gaap:CostOfSalesMember 2019-07-01 2019-09-30 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0000816284 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000816284 us-gaap:CostOfSalesMember 2018-01-01 2018-09-30 0000816284 us-gaap:CostOfSalesMember 2019-01-01 2019-09-30 0000816284 us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0000816284 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0000816284 celg:PerformanceBasedRestrictedStockUnitsMember 2018-12-31 0000816284 us-gaap:EmployeeStockOptionMember 2018-12-31 0000816284 celg:JunoTherapeuticsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-07-01 2018-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-07-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-09-30 0000816284 celg:JunoTherapeuticsMember us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0000816284 celg:OtherCollaborationAgreementsMember 2018-07-01 2018-09-30 0000816284 celg:OtherCollaborationAgreementsMember 2019-07-01 2019-09-30 0000816284 celg:OtherCollaborationAgreementsMember 2019-01-01 2019-09-30 0000816284 celg:OtherCollaborationAgreementsMember 2018-01-01 2018-09-30 0000816284 celg:OtherCollaborationAgreementsMember 2019-09-30 0000816284 celg:OtherCollaborationAgreementsMember 2018-12-31 0000816284 celg:JounceMember 2019-07-22 2019-07-22 0000816284 srt:MaximumMember celg:OfficeandResearchFacilitiesMember 2019-09-30 0000816284 srt:MaximumMember celg:OfficeandOtherEquipmentMember 2019-09-30 0000816284 srt:MinimumMember us-gaap:AutomobilesMember 2019-09-30 0000816284 srt:MaximumMember us-gaap:AutomobilesMember 2019-09-30 0000816284 srt:MinimumMember celg:OfficeandResearchFacilitiesMember 2019-09-30 0000816284 srt:MinimumMember celg:OfficeandOtherEquipmentMember 2019-09-30 0000816284 2017-10-02 2017-10-02 0000816284 2017-06-14 2017-06-14 xbrli:shares iso4217:USD celg:right iso4217:USD xbrli:shares xbrli:pure celg:state celg:plaintiff


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
(Mark One)
     QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2019
or
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___________ to ___________
Commission File Number 001-34912
CELGENE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware
 
22-2711928
State or Other Jurisdiction of
Incorporation or Organization
 
I.R.S. Employer Identification No.
 
 
 
 
86 Morris Avenue
 
 
Summit,
NJ
 
07901
Address of Principal Executive Offices
 
Zip Code
(908)
673-9000
Registrant’s Telephone Number, Including Area Code
 
Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $.01 per share
CELG
NASDAQ Global Select Market
Contingent Value Rights
CELGZ
NASDAQ Global Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes  x    No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
Accelerated filer 
Non-accelerated filer 
Smaller reporting company
 
 
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o  
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes    No  x


As of October 29, 2019, 711,714,480 shares of Common Stock, par value $.01 per share, were outstanding.




CELGENE CORPORATION
 
FORM 10-Q TABLE OF CONTENTS
 
 
 
 
Page No.

 
 
 
 
 
 
 
 
 

 
 
 
 

 
 
 
 

 
 
 
 

 
 
 
 
8

 
 
 
 

 
 
 

 
 
 

 
 
 

 
 
 
 
 
 
 
 
 
 

 
 
 

 
 
 

 
 
 

 
 
 
 


2



PART I – FINANCIAL INFORMATION
 
Item 1. Financial Statements (Unaudited)
 
CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(Dollars in millions, except per share amounts)
 
 
 
Three-Month Periods Ended September 30,
 
Nine-Month Periods Ended September 30,
 
 
2019
 
2018
 
2019
 
2018
Revenue:
 
 
 
 
 
 
 
 
Net product sales
 
$
4,518

 
$
3,890

 
$
12,941

 
$
11,229

Other revenue
 
2

 
2

 
4

 
15

Total revenue
 
4,520

 
3,892

 
12,945

 
11,244

Expenses:
 
 

 
 

 
 

 
 

Cost of goods sold (excluding amortization of acquired intangible assets)
 
167

 
157

 
458

 
418

Research and development
 
1,167

 
1,081

 
3,483

 
4,535

Selling, general and administrative
 
781

 
746

 
2,347

 
2,400

Amortization of acquired intangible assets
 
109

 
127

 
327

 
341

Acquisition/integration related charges and restructuring, net
 
32

 
101

 
245

 
166

Total costs and expenses
 
2,256

 
2,212

 
6,860

 
7,860

Operating income
 
2,264

 
1,680

 
6,085

 
3,384

Other income and (expense):
 
 

 
 

 
 

 
 

Interest and investment income, net
 
45

 
8

 
117

 
30

Interest (expense)
 
(190
)
 
(193
)
 
(574
)
 
(551
)
Other (expense) income, net
 
(202
)
 
(117
)
 
(76
)
 
852

Income before income taxes
 
1,917

 
1,378

 
5,552

 
3,715

Income tax provision
 
226

 
296

 
745

 
742

Net income
 
$
1,691

 
$
1,082

 
$
4,807

 
$
2,973

Net income per common share:
 
 

 
 

 
 

 
 

Basic
 
$
2.38

 
$
1.54

 
$
6.81

 
$
4.12

Diluted
 
$
2.32

 
$
1.50

 
$
6.63

 
$
4.02

Weighted average shares:
 
 

 
 

 
 

 
 

Basic
 
709.4

 
702.0

 
706.2

 
722.0

Diluted
 
729.5

 
719.7

 
725.5

 
740.4

 
See accompanying Notes to Unaudited Consolidated Financial Statements

3


CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
(Dollars in millions)

 
 
Three-Month Periods Ended September 30,
 
Nine-Month Periods Ended September 30,
 
 
2019
 
2018
 
2019
 
2018
Net income
 
$
1,691

 
$
1,082

 
$
4,807

 
$
2,973

Other comprehensive (loss) income:
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
(33
)
 
(2
)
 
(34
)
 
(14
)
 
 
 
 
 
 
 
 
 
Net unrealized gains related to cash flow hedges:
 
 
 
 
 
 
 
 
Unrealized holding gains
 
80

 
54

 
119

 
181

Tax benefit
 

 

 

 
1

Unrealized holding gains, net of tax
 
80

 
54

 
119

 
182

 
 
 
 
 
 
 
 
 
Reclassification adjustment for (gains) losses included in net income
 
(18
)
 
(13
)
 
(62
)
 
27

Tax (benefit)
 
(1
)
 

 
(1
)
 
(1
)
Reclassification adjustment for (gains) losses included in net income, net of tax
 
(19
)
 
(13
)
 
(63
)
 
26

 
 
 
 
 
 
 
 
 
Excluded component related to cash flow hedges:
 
 
 
 
 
 
 
 
Amortization of excluded component (gains)
 
(1
)
 
(3
)
 
(4
)
 
(18
)
Reclassification of realized excluded component losses to net income
 
2

 
6

 
5

 
23

Net reclassification adjustment included in net income
 
1

 
3

 
1

 
5

 
 
 
 
 
 
 
 
 
Net unrealized gains (losses) on debt securities available-for-sale:
 
 
 
 
 
 
 
 
Unrealized holding gains (losses)
 

 

 
1

 
(9
)
Tax benefit
 

 

 

 
2

Unrealized holding gains (losses), net of tax
 

 

 
1

 
(7
)
 
 
 
 
 
 
 
 
 
Reclassification adjustment for (gains) losses included in net income
 

 

 
(1
)
 
18

Tax (benefit)
 

 

 

 
(4
)
Reclassification adjustment for (gains) losses included in net income, net of tax
 

 

 
(1
)
 
14

Total other comprehensive income
 
29

 
42

 
23

 
206

Comprehensive income
 
$
1,720

 
$
1,124

 
$
4,830

 
$
3,179


See accompanying Notes to Unaudited Consolidated Financial Statements

4



CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in millions, except per share amounts)
 
 
September 30,
2019
 
December 31,
2018
Assets
 

 
 

Current assets:
 

 
 

Cash and cash equivalents
$
9,604

 
$
4,234

Debt securities available-for-sale
14

 
496

Equity investments with readily determinable fair values
1,279

 
1,312

Accounts receivable, net of allowances of $52 and $38 as of September 30, 2019 and December 31, 2018, respectively
2,374

 
2,066

Inventory
451

 
458

Other current assets
732

 
501

Total current assets
14,454

 
9,067

Property, plant and equipment, net
1,415

 
1,367

Intangible assets, net
16,387

 
16,213

Goodwill
8,003

 
8,003

Other non-current assets
1,104

 
830

Total assets
$
41,363

 
$
35,480

Liabilities and Stockholders’ Equity
 

 
 

Current liabilities:
 

 
 

Short-term borrowings and current portion of long-term debt
$
1,498

 
$
501

Accounts payable
421

 
418

Accrued expenses and other current liabilities
2,964

 
2,987

Income taxes payable
82

 
78

Current portion of deferred revenue
44

 
73

Total current liabilities
5,009

 
4,057

Deferred revenue, net of current portion
16

 
73

Income taxes payable
2,454

 
2,190

Deferred income tax liabilities
2,854

 
2,753

Other non-current liabilities
654

 
477

Long-term debt, net of discount
18,289

 
19,769

Total liabilities
29,276

 
29,319

Commitments and Contingencies (See Note 15)


 


Stockholders’ Equity
 

 
 

Preferred stock, $.01 par value per share, 5.0 million shares authorized; none outstanding as of September 30, 2019 and December 31, 2018

 

Common stock, $.01 par value per share, 1,150.0 million shares authorized; issued 992.6 million and 981.5 million shares as of September 30, 2019 and December 31, 2018, respectively
10

 
10

Common stock in treasury, at cost; 281.2 million and 281.3 million shares as of September 30, 2019 and December 31, 2018, respectively
(26,334
)
 
(26,336
)
Additional paid-in capital
16,072

 
14,978

Retained earnings
22,366

 
17,559

Accumulated other comprehensive (loss)
(27
)
 
(50
)
Total stockholders’ equity
12,087

 
6,161

Total liabilities and stockholders’ equity
$
41,363

 
$
35,480

 
See accompanying Notes to Unaudited Consolidated Financial Statements

5



CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in millions)
 
Nine-Month Periods Ended September 30,
 
2019
 
2018
Cash flows from operating activities:
 

 
 

Net income
$
4,807

 
$
2,973

Adjustments to reconcile net income to net cash provided by operating activities:
 

 
 

Depreciation
142

 
119

Amortization
344

 
346

Impairment charges

 
30

Deferred income taxes
(20
)
 
(10
)
Change in value of contingent consideration and success payments
(18
)
 
74

Net loss on sales of debt securities available-for-sale

 
18

Fair value adjustments on equity investments
100

 
(830
)
Share-based compensation expense
658

 
731

Share-based employee benefit plan expense

 
33

Derivative instruments
31

 
(11
)
Other, net
(74
)
 
(14
)
Change in current assets and liabilities, excluding the effect of acquisitions and disposals:
 

 
 

Accounts receivable
(331
)
 
(225
)
Inventory
7

 
31

Other operating assets
(100
)
 
(374
)
Accounts payable and other operating liabilities
84

 
(66
)
Income tax payable
265

 
(22
)
Payment of contingent consideration
(29
)
 
(22
)
Deferred revenue
(51
)
 
47

Net cash provided by operating activities
5,815

 
2,828

Cash flows from investing activities:
 

 
 

Proceeds from sales of debt securities available-for-sale
976

 
3,383

Purchases of debt securities available-for-sale
(493
)
 
(240
)
Capital expenditures
(197
)
 
(232
)
Proceeds from sales of equity investment securities
20

 
96

Purchases of equity investment securities
(107
)
 
(176
)
Payments for acquisition of business, net of cash acquired

 
(8,648
)
Payment for acquisition of intangible asset
(400
)
 

Net cash (used in) investing activities
(201
)
 
(5,817
)
Cash flows from financing activities:
 

 
 

Payment for treasury shares

 
(6,096
)
Proceeds from short-term borrowing

 
5,709

Principal repayments on short-term borrowing

 
(5,710
)
Proceeds from issuance of long-term debt

 
4,452

Principal repayments on current portion of long-term debt
(500
)
 

Payment of contingent consideration
(82
)
 
(40
)
Net proceeds from share-based compensation arrangements
363

 
129

Net cash (used in) financing activities
(219
)
 
(1,556
)
Effect of currency rate changes on cash and cash equivalents
(25
)
 
12

Net increase (decrease) in cash and cash equivalents
5,370

 
(4,533
)
Cash and cash equivalents at beginning of period
4,234

 
7,013

Cash and cash equivalents at end of period
$
9,604

 
$
2,480


 See accompanying Notes to Unaudited Consolidated Financial Statements




6







CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS - (Continued)
(Unaudited)
(Dollars in millions)
 
 
Nine-Month Periods Ended September 30,
 
2019
 
2018
Supplemental schedule of non-cash investing and financing activity:
 

 
 

Change in net unrealized (gain) loss on debt securities available-for-sale
$
(1
)
 
$
9

Increase in acquired intangible asset relating to deferred taxes
119

 

Supplemental disclosure of cash flow information:
 

 
 

Interest paid
671

 
581

Income taxes paid
503

 
974

  
See accompanying Notes to Unaudited Consolidated Financial Statements

7



CELGENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(Unaudited)
(Dollars in millions)
 
 
Common
Stock
 
Treasury
Stock
 
Additional
Paid-in
Capital
 
Retained
Earnings
 
Accumulated Other Comprehensive Income (Loss)
 
Stockholders'
Equity
Balances as of December 31, 2018
 
$
10

 
$
(26,336
)
 
$
14,978

 
$
17,559

 
$
(50
)
 
$
6,161

Net income
 

 

 

 
1,545

 

 
1,545

Other comprehensive income
 

 

 

 

 
18

 
18

Exercise of stock options and conversion of restricted stock units
 

 
(12
)
 
164

 

 

 
152

Issuance of common stock for employee benefit plans
 

 
50

 
(18
)
 

 

 
32

Expense related to share-based compensation
 

 

 
257

 

 

 
257

Balances as of March 31, 2019
 
$
10

 
$
(26,298
)
 
$
15,381

 
$
19,104

 
$
(32
)
 
$
8,165

Net income
 

 

 

 
1,571

 

 
1,571

Other comprehensive (loss)
 

 

 

 

 
(24
)
 
(24
)
Exercise of stock options and conversion of restricted stock units
 

 
(33
)
 
147

 

 

 
114

Expense related to share-based compensation
 

 

 
225

 

 

 
225

Balances as of June 30, 2019
 
$
10

 
$
(26,331
)
 
$
15,753

 
$
20,675

 
$
(56
)
 
$